LAB - Standard BioTools Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$3.25
DETAILS
HIGH:
$3.25
LOW:
$3.25
MEDIAN:
$3.25
CONSENSUS:
$3.25
UPSIDE:
215.53%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 49.9% |
| EBIT Margin | -109.3% |
| EBITDA Margin | -101.2% |
| Operating Margin | -109.3% |
| Pretax Margin | -113.3% |
| Cont. Ops Margin | -68.9% |
| Net Margin | -87.8% |
| Bottom Line Margin | -87.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.19 |
| Quick Ratio | 4.01 |
| Solvency Ratio | -0.473 |
| Cash Ratio | 1.09 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-6.52
Peers avg: 30.4
|
| PEG Ratio | 0.11 |
| Forward PEG | 0.11 |
| Price/Book | 1.15 |
| Price/Sales | 5.72 |
| Price/FCF | -5.91 |
| Price/Op Cash Flow | -6.57 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0543 |
| Debt/Equity | 0.0727 |
| Debt/Capital | 0.0677 |
| Long-Term Debt/Capital | 0.0007 |
| Financial Leverage | 1.34 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.26 |
| Operating Cash Flow Ratio | -0.686 |
| Operating Cash Flow/Sales | -87.1% |
| Free Cash Flow/Operating Cash Flow | 111.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -8.78 |
| Interest Coverage | -3588.6538 |
| Short-Term Operating Cash Flow Coverage | -13.54 |
| Operating Cash Flow Coverage | -2.41 |
| Capital Expenditure Coverage | -8.95 |
| Dividend + Capital Expenditure Coverage | -8.95 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.22 |
| EPS | -0.196 |
| Debt/Share | 0.0808 |
| Cash/Share | 0.49 |
| Book Value/Share | 1.11 |
| Tangible BV/Share | 1.11 |
| Equity/Share | 1.11 |
| Operating Cash Flow/Share | -0.195 |
| Capital Expenditure/Share | 0.022 |
| FCF/Share | -0.217 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.775 |
| Earnings Before Tax/EBIT | 1.036 |
| Price/Fair Value | 1.15 |
| Debt/Market Cap | 0.0119 |
| Effective Tax Rate | 39.2% |
| Enterprise Value Multiple | -4.65 |